LA BioMed Announces $50 Million Bond Sale to Benefit Future High-tech Construction

Demand for organization’s first bond issue was more than twice the offering size

Superbug May Soon Be Killed By LA Biomed Led Research Combating Deadly Drug-Resistant Bacteria

First of its kind study identifies vaccination potential that could save 23,000 people annually

Two Forms of Male Birth Control Are Closer to Reality Thanks to New Research

Male Pill and Gel Would Take Steps to Prevent 40 Percent of Unplanned Pregnancies

LA BioMed Spinoff Announces Publishing of Phase 3 Trial Results from Sickle Cell Disease Drug

Results of Emmaus Life Science’s clinical trial published in The New England Journal of Medicine to grow worldwide awareness of debilitating disease

Putting an End to Deadly Antibiotic Resistance Caused by Over-Prescription

Successful Behavioral Interventions to Curb Over-Prescribing Found Cost Effective; LA BioMed Researcher’s New Study’s Results Have Life-Saving Implications.

Disease Screening in Newborns Given Boost from Federal Grant

NIH funded research led by Dr. Rie Sakai-Bizmark has potential to save the lives of hundreds of newborn babies annually

LA BioMed helps drive LA County's ranking as national Top-10 BioPharma Cluster

A new 78,000 SF research building and bioscience incubator are set to open in early 2019, further securing LA BioMed's contribution to biotech leadership in Southern California

Topping-Off Ceremony of 4-Story Research Building at LA BioMed Propels LA County’s 1st Biotech Hub

78,000 SF building to house new bioscience incubator on 11.5-acre campus that with Harbor- UCLA Medical Center and LA BioMed is on track to become the first biotech hub in the County